Continuous growth in cell-based research are driving the US Biotechnology Market
Published: Sep 2020
The US biotechnology market is projected to grow at a significant CAGR of 7.4% during the forecast period (2020-2026). The increasing popularity of cell culture in drug discovery, cancer treatment, and vaccine production has promoted the funding of cell-based research.
Adoption of advanced healthcare technologies are driving the UK Biotechnology Market
Published: Sep 2020
UK biotechnology market is projected to grow at a significant CAGR of 7.1% during the forecast period (2020-2026). Technological advancements in the industry are expected to boost the biotechnology market in UK during the forecast period.
Rising funding initiatives will continue steering the North American Biotechnology Market
Published: Sep 2020
North American biotechnology market is projected to grow at a significant CAGR of 7.3% during the forecast period (2020-2026). The increasing popularity of 3D cell culture in drug discovery, cancer treatment, vaccine production has promoted the funding of cell-based research
Increasing demand for precision medicine is driving the Indian Biotechnology Market
Published: Sep 2020
Indian biotechnology market is projected to grow at a significant CAGR of 8.1% during the forecast period (2020-2026). The increasing demand for precision and personalized medicine, the advancement of technology, application in drug development and increasing application in clinical diagnostics are the factors that fuel the growth of the biotechnology market in the country.
Advancements in next-generation sequencing are escalating the European Biotechnology Market
Published: Sep 2020
The European biotechnology market is projected to grow at a significant CAGR of 6.9% during the forecast period (2020-2026).
Advancement in forensics is escalating the Asia-Pacific Biotechnology Market
Published: Sep 2020
Asia-Pacific biotechnology market is projected to grow at a significant CAGR of 7.1% during the forecast period (2020-2026). Rising crime cases and the adoption of forensics for solving the cases is considered one of the major factors which are augmenting the adoption of biotechnology in the region.
Awareness Programs for Mental Health will Continue Driving the US Schizophrenia Drugs Market
Published: Sep 2020
The US schizophrenia drugs market is projected to grow at a significant CAGR of 2.7% during the forecast period (2020-2026). The rising awareness programs for mental health is acting as one prominent factor in the market growth in the US. The first Wednesday in November each year is celebrated as National Stress Awareness Day in the US. Various programs are conducted on this day to create awareness related to the treatment available for the management of schizophrenia.
Established Mental Health Services Continue Driving UK Schizophrenia Drugs Market
Published: Sep 2020
UK schizophrenia drug market is projected to grow at a significant CAGR of around 2.7% during the forecast period (2020-2026). UK has a well-developed healthcare infrastructure with an established mental health facility. National Health Services (NHS) England spends $7.2 million per year on mental health services for ex-service personnel, in addition to the $12.7 billion spending on mental health for the general population, therefore, create significant market growth in the country.
Government Support for Anxiety Disorder will Continue Steering the North American Schizophrenia Drugs Market
Published: Sep 2020
North American schizophrenia drugs market is projected to grow at a significant CAGR of 2.1% during the forecast period (2020-2026). The increasing incidence of anxiety disorders in North America is generating the demand for different types of medication and therapies for its treatment and thereby is expected to propel the growth of the schizophrenia drugs market in the region.
Rising Schizophrenia in Female Population is Offering Steady Growth to Indian Schizophrenia Drugs Market
Published: Sep 2020
Indian schizophrenia drugs market is projected to grow at a significant CAGR of 4.0% during the forecast period (2020-2026). The major contributors in the market are the female population suffering from mental health issues in the country. There is no gender difference in schizophrenia; however, a stress and mental health are some factors leads to schizophrenia. In India, women face a lot of problems in India, especially in relation to pregnancy, marriage, childbirth, and menopause.